94270 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen atoms attached in position 2 or 4
Sub-classes:CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#2Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition
#3TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES
#4CRYSTAL FORMS OF N-(3-FLUOROPHENYL)-6-(6,7-DIMETHOXYQUINOLIN-4-OXY)-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXAMIDE METHANESULFONATE AND PREPARATION METHOD THEREOF
#5CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#6CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#7CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#8CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#9Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#10PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#11HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS
#12CABOZANTINIB SALT WITH L-(+)-TARTARIC ACID AND SOLID FORMS THEREOF
#13SMALL MOLECULES FOR TREATING CANCER, INHIBITING CHEMOKINE ACTIVITY AND/OR INDUCING CELL DEATH
#14Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#15RARE EARTH COMPLEX
#16CABOZANTINIB COMPOSITIONS AND METHODS OF USE
#17COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#18GLUN2B-SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS WITH ENHANCED POTENCY AT ACIDIC PH
#19Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof
#20GLUN2B-SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS WITH ENHANCED POTENCY AT ACIDIC PH
#21METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
#22Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#23A PHARMACEUTICAL PRODUCT CONTAINING TASQUINIMOD AND A METHOD FOR ASSESSING THE PURITY OF SAID PRODUCT
#24Method of Treating Cancer
#25INHIBITORS OF MET KINASE
#26Compounds for the Treatment of Kinase-Dependent Disorders
#27Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#28Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
#29HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN
#30CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE
#31Method of treating cancer
#32QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#33Inhibitors of MET kinase
#34Notch Inhibitors and Uses Thereof
#35Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#36Heterocyclic compounds for the treatment of neurological and psychological disorders
#37SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1
#38CRYSTALLINE FORM OF FLUVATINIB OR FLUVATINIB METHANESULFONATE AND PREPARATION METHOD THEREFOR
#39Crystalline form of compound, method for preparing the same, pharmaceutical composition and use
#40Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
#41Process for the preparation of aripiprazole lauroxil
#42Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs
#43Quinolyl-containing compound and pharmaceutical composition, and use thereof
#44Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#45Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
#46Compounds for the Treatment of Kinase-Dependent Disorders
#47PAN-KIT KINASE INHIBITOR HAVING QUINOLINE STRUCTURE AND APPLICATION THEREOF
#48Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#49LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#50Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
#51Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use
#52C-met modulators and methods of use
#53ANTI-BLUE LIGHT COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF
#54Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#55Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#56Platform drug delivery system utilizing crystal engineering and theanine dissolution
#57Carbamate and urea compounds as multikinase inhibitors
#58Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#59Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer
#60Multi-tyrosine kinase inhibitors derivatives and methods of use
#61Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof
#62Compounds for the treatment of kinase-dependent disorders
#63Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
#64Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#65Heterocyclic compounds for the treatment of neurological and psychological disorders
#66Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death
#67ALKOXYCARBONATE ESTER PRODRUGS FOR USE AS ANTIMALARIAL AGENTS
#68C-Met Modulators and Methods of Use
#69Methods of using c-Met modulators
#70Method of treating cancer
#71Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#72Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
#73Method of Treating or Inhibiting Malaria
#74NOVEL ANTI-INFLAMMATORY AGENTS
#75LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#76Crystalline form of aripiprazole
#77Lactam compound, preparation method and use thereof
#78Quinoline derivative in crystal form
#79QUINOLONE-3-DIARYLETHERS
#80Prodrugs of Nh-acidic compounds
#81Methods and compositions for inhibition of bromodomain-containing proteins
#82Multi-tyrosine kinase inhibitors derivatives and methods of use
#83PRODRUGS OF NH-ACIDIC COMPOUNDS
#84Heterocyclic compounds for the treatment of neurological and psychological disorders
#85CRYSTAL OF QUINOLINE DERIVATIVE
#86Tyrosine kinase inhibitor and application thereof
#87LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF
#88Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#89Heterocyclic compounds for the treatment of neurological and psychological disorders
#90Mutant IDH1 inhibitors useful for treating cancer
#91Organomedicinals for imaging and treatment of neurodegenerative disorders
#92Prodrugs of NH-acidic compounds
#93Quinolone-3-diarylethers
#94PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES
#95PROCESS FOR PREPARING ARIPIPRAZOLE LAUROXIL AND INTERMEDIATES THEREOF
#96Quinoline carboxamides for use in the treatment of multiple myeloma
#97Heterocyclic compounds for the treatment of neurological and psychological disorders
#98TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#99Methods and compositions for inhibition of bromodomain-containing proteins
#100Haptens of aripiprazole
#101Cabozantinib salts and their use as anti-cancer agents
#102Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
#103Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#104Alkaloids and their preparation and application as anti-HSV-1 agents
#105Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
#106Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#107TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#108C-met modulators and methods of use
#109Compounds active towards bromodomains
#110Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
#111NOVEL ANTI-INFLAMMATORY AGENTS
#112Substituted naphthyridine and quinoline compounds as MAO inhibitors
#113Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
#114Quinoline carboxamides for use in the treatment of multiple myeloma
#115Process for synthesizing oxidized lactam compounds
#116TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#117Quinolone derivatives as antibacterials
#118Method of preparing fluorine-18 labeled Cabozantinib and its analogs
#119Protein kinase conjugates and inhibitors
#120Haptens of aripiprazole
#121Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
#122Quinolone-3-diarylethers
#123Prodrugs of NH-acidic compounds
#124Reduction-triggered antibacterial sideromycins
#125Heterocyclic compounds for the treatment of neurological and psychological disorders
#126HDAC inhibitors
#127Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof
#128Substituted naphthyridine and quinoline compounds as MAO inhibitors
#129Compound, optical resolution method, and derivative of an optical isomer of an amino acid
#130Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#131Methods and compositions for inhibition of bromodomain-containing proteins
#132Chiral compounds, compositions, products and methods employing same
#133Process for synthesizing oxidized lactam compounds
#134Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
#135Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and its crystalline
#136Phenoxyalkylamine compound
#137Therapeutic hydroxyquinolones
#138Quinolinone derivatives
#139Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#140Aryloxyurea compound and pest control agent
#141Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
#1423-O-heteroaryl-ingenol
#143ROR modulators and their uses
#144Compound, optical resolution method, and derivative of an optical isomer of an amino acid
#145Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
#146Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
#147Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
#148Methods of treating lymphoma and rheumatoid arthritis with cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)amino]acetate
#149Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#150Subunit selective NMDA receptor potentiators for the treatment of neurological conditions
#151Quinolinone carboxamide inhibitors of endothelial lipase
#152Method for producing optically active tetrahydroquinolines
#153Method for producing fine particles of aripiprazole anhydride crystals B
#154Prodrugs of NH-acidic compounds
#155Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
#156Haptens of aripiprazole
#157C-Met Modulators and Method of Use
#158METHOD OF TREATING LUNG ADENOCARCINOMA
#159Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
#160Method of Treating Cancer
#161Method of Treating Cancer
#162Process for synthesizing oxidized lactam compounds
#163Quinolone compound and pharmaceutical composition
#164Process for preparing quinoline-3-carboxamide derivatives
#165Quinolinone derivatives
#166Quinolinone derivatives
#167Process for producing 4-carbonyloxyquinoline derivatives
#168Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
#169Aryloxyurea compound and pest control agent
#170Heterocyclic derivative and pharmaceutical composition comprising the same
#171Chiral compounds, compositions, products and methods employing same
#172ANTAGONISTS OF THE TRPV1 RECEPTOR AND USES THEREOF
#173Quinolone compound and pharmaceutical composition
#174Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#175Low hygroscopic aripiprazole drug substance and processes for the preparation
#176Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#177THERAPEUTIC AGENT FOR CHRONIC PAIN
#178Heteroaromatic phthalonitriles
#179C-Met Modulators and Method of Use
#180Quinoline derivatives as anti-cancer agents
#181Quinolone derivative or pharmaceutically acceptable salt thereof
#182Compounds as c-Met kinase inhibitors
#183Quinolinone PDE2 inhibitors
#184Anti-inflammatory agents
#185Heterocyclic substituted acardite derivate and application thereof
#186(L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
#187Subunit selective NMDA receptor potentiators for the treatment of neurological conditions
#188C-met modulators and method of use
#189Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#190QUINOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS
#191Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
#192Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
#193Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#194Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
#195COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND CANCER
#196Aurora kinase modulators and methods of use
#197Process for synthesizing oxidized lactam compounds
#198Quinolone compound and pharmaceutical composition
#199PIPERAZINE DERIVATIVES
#200Azaquinolones that inhibit prolyl hydroxylase
#201Treatment of lupus nephritis using laquinimod
#202Antitumor agent for thyroid cancer
#203Optically active cyclic alcohol compound
#204Process for producing 6-aryloxyquinoline derivative and intermediate therefor
#205Protein kinase conjugates and inhibitors
#206Heteroaromatic phthalonitriles
#207Process for preparing quinoline-3-carboxamide derivatives
#208[4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials
#209C-Met Modulators and Method of Use
#210Carboxylic acid compound
#211QUINOLINE COMPOUNDS AND METHODS OF USE
#212Quinoline compound and pharmaceutical composition, preparation method and uses thereof
#213Heterocyclic compounds for the treatment of neurological and psychological disorders
#214Prodrugs of NH-acidic compounds
#215USE OF IMMIDAZOQUINOLINAMINES AS ADJUVANTS IN DNA VACCINATION
#216In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
#217MORPHOLINYL AND PYRROLIDINYL ANALOGS
#218Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
#219Amino ester derivatives, sailts thereof and methods of use
#220PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA, COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT
#221Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
#222Optically active cyclic alcohol compound and method for preparing the same
#223Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#224PROCESS FOR PREPARING CRYSTALLINE ARIPIPRAZOLE
#225Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
#226Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide
#2274-ARYLOXYQUINOLIN-2(1H)-ONES AS MTOR KINASE AND PI3 KINASE INHIBITORS, FOR USE AS ANTI-CANCER AGENTS
#228Composition for treatment of undifferentiated gastric cancer
#229Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases
#230Morpholinyl and pyrrolidinyl analogs
#231Antitumor agent for undifferentiated gastric cancer
#232METHOD OF PREPARING HUPERZINE A AND DERIVATIVES THEREOF
#233SYNTHESES AND PREPARATIONS OF POLYMORPHS OF CRYSTALLINE ARIPIPRAZOLE
#234ANTITUMOR AGENT FOR THYROID CANCER
#235ANTI-PROLIFERATIVE COMPOUNDS FROM A 3-ARYL-COUMARINE OR 3-ARYL-QUINOLIN-2-ONE AND USES THEREOF
#236Quinolone derivative or pharmaceutically acceptable salt thereof
#237c-Met modulators and methods of use
#238Quinolones and azaquinolones that inhibit prolyl hydroxylase
#239c-Met modulators and methods of use
#240Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
#241Antitumor agents
#242Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
#243Phenylalanine derivatives
#244Inhibitors of human immunodeficiency virus replication
#245Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same
#246NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#247MULTIPLY-SUBSTITUTED TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
#248NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#249NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#2508-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists
#251Morpholinyl and pyrrolidinyl analogs
#252Process for production of carbostyril compound
#253Certain substituted quinolones, compositions, and uses thereof
#254Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity
#255Vaccination
#256c-Met modulators and method of use
#257PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE
#258c-Met modulators and method of use
#259Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#260Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#261Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#262Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#263Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#264Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#265Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#266Diaryl Substituted Pyridinones
#267Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis
#268Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
#269Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
#270Antitumor agents
#271c-Met modulators and methods of use
#272Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
#273Benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents
#274Novel compounds for treatment of cancer and disorders associated with angiogenesis function
#275Diaryl substituted pyridinones
#276Cinnamoyl compound and use of the same
#2773-aryl-3-methyl-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
#278Processes for preparing 7-hydroxy-3,4-dihydro-2(1H)-quinolinone and the use in aripiprazole preparation thereof
#279Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
#280Quinolinones as prostaglandin receptor ligands
#281Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
#282Substituted pyridinones
#283Crystalline forms of aripiprazole
#284(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
#285Anti-infective agents
#286Multi-tyrosine kinase inhibitors derivatives and methods of use